iCare’s Illume solution uses iCare DRSplus True Color confocal imaging technology and Thirona’s RetCAD software to detect signs of retinal pathologies.
It can quickly and accurately identify abnormal changes in the retina, allowing healthcare professionals to diagnose and treat the disease early.
Artificial intelligence (AI) brings many benefits to retinal screening. It can help identify age-related macular degeneration and diabetic retinopathy, allowing for earlier intervention and better patient outcomes.
Non-expert personnel can use the fully automated iCare Illume screening solution. The results classified by severity help identify patients most needing specialised care.
iCare Illume Connect offers a focussed and controlled referral flow to connect you and the patient to other healthcare providers, with relevant information for better collaborative care.
Pictured is an example iCare Illume AI report for a patient with age-related macular degeneration.
Visit: www.icare-world.com